The Goldman Sachs Group, Inc. (GS)
After hours:
| Previous close | 306.80 |
| Open | 312.72 |
| Bid | 315.16 x 900 |
| Ask | 316.40 x 1100 |
| Day's range | 311.07 - 321.83 |
| 52-week range | 293.90 - 426.16 |
| Volume | |
| Avg. volume | 2,883,890 |
| Market cap | 108.739B |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | 6.14 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 8.00 (2.61%) |
| Ex-dividend date | 31 May 2022 |
| 1y target est | N/A |
- GlobeNewswire
Auto fintech Caribou raises $115 million in Series C funding, valuing company at $1.1 billion
Funding round led by existing investor Goldman Sachs Asset ManagementWASHINGTON, May 20, 2022 (GLOBE NEWSWIRE) -- Caribou, the auto fintech whose mission is to help people take control of their car payments, today announced it has closed $115 million in an oversubscribed Series C funding round, which brings the company’s valuation to $1.1 billion. The round was led by Goldman Sachs Asset Management (Goldman Sachs), with participation from new investors, including Innovius Capital and Harmonic, a
- GlobeNewswire
Apollo Funds Complete Acquisition of Majority Stake in Novolex
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that funds managed by Apollo affiliates (the “Apollo Funds”) have completed the acquisition of a majority stake in Novolex Holdings LLC (“Novolex” or the “Company”), a leading global manufacturer of diverse and sustainable packaging products for the foodservice, delivery and carryout, food processor and industrial markets, from funds managed by Carlyle (NASDAQ: CG). Carlyle will retain a minority stake in the Company
- PR Newswire
Omega Healthcare completes acquisition of ApexonHealth and Vasta Global
Omega Healthcare, a leading technology-enabled healthcare management solutions provider, today announced its acquisition of ApexonHealth, an AI and automation-based revenue cycle management and payor solutions provider, and Vasta Global, a provider of real-world data abstraction and analytics for the oncology market.
